REGULATORY

MHLW to Kick Off Debates on PMD Act Amendment on Feb. 9

February 5, 2024

- Only subscribers can save articles.
  
  Sign In
  
  Subscribe

The Ministry of Health, Labor and Welfare (MHLW) will hold a meeting of a key advisory panel on February 9 to start discussions towards a series of system reforms, including an amendment of the Pharmaceuticals and Medical Devices (PMD) Act.…

To read the full story

MHLW Panel to Draw Up Report by Year-End towards Amendment of PMD Act
February 13, 2024
Legal Changes on Horizon for GMP Inspection Authorities, Other Regulation Panel Topics?
February 7, 2024
MHLW Publishes Report on Drug Marketing System towards PMD Law Amendment
January 17, 2024

REGULATORY

Trump Signs Off on Up to 100% Tariffs on Drugs; Japan Rate Set at 15%
April 3, 2026
Japan Launches Task Force to Secure Critical Supplies amid Middle East Crisis
April 3, 2026
MHLW Streamlines Lot Release Procedures for Vaccines, Blood Products
April 3, 2026
MHLW Allows Outer Packaging Labeling for Regenerative Medicine Products
April 3, 2026
MHLW’s Drug Supply Monitoring System Now Up and Running
April 3, 2026

Chuikyo Debate on FY2026 Drug Pricing Reform

Chuikyo OKs New CEA Handling, with Third-Party Verification Ahead

Japan’s cost-effectiveness assessment (CEA) panel has approved a revised handling policy for the CEA system for FY2026, with the health…

COMMENTARY

Japan’s FY2026 R&D Tax Credit Reform Wins Broad Industry Backing

By Sakura Kono

Japan will overhaul its R&D tax credit regime in its FY2026 reform, introducing a new strategic category alongside existing frameworks.…

COLUMN

Strategic Talent Acquisition in the Japanese Life Sciences Sector: Your Market Intelligence Briefing

By Philip Carrigan

Focus: How to Get the Talent You Need in a Tough MarketThe Japanese life sciences sector presents a challenging landscape for global companies. To succeed, you must move beyond reactive hiring and adopt a truly strategic talent acquisition model. Our…